Postpartum acute exacerbation of chronic hepatitis C with complete response to interferon-α

Journal of Gastroenterology

Volumn 37, Issue 8, 2002, Pages 658-662

  Oketani, Makoto ^a   Shibatou, Toshihiko ^a   Yamashita, Katsuhisa ^a   Arima, Takushi ^a   Arima, Terukatsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Acute exacerbation; Cytokine receptors; Cytokines; Hepatitis C virus; Interferon; Postpartum period

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; AUTOANTIBODY; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 8; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; ALANINE AMINOTRANSFERASE; BILIRUBIN; FAS ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; JAUNDICE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SUPERINFECTION; TH1 CELL; TH2 CELL; VIRUS LOAD; BLOOD; PUERPERAL DISORDER;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, CD95; BILIRUBIN; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON-ALPHA; PREGNANCY; PUERPERAL DISORDERS; RECEPTORS, CYTOKINE;

EID: 0036696002     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200105     Document Type: Article

References (34)

1. Tateda A, Kikuchi K, Numazaki Y, Schirachi R, Ishida N. Non-B hepatitis in Japanese recipients of blood transfusion: clinical and serological studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 1979:139:511-8.
2. Kryger P, Christoffersen P, Aldershivile J, Mathiesen LR, Nielsen JO, Tage-Jensen U, and The Copenhagen Hepatitis Acute Programme. The long-term prognosis of nontransfusion-associated non-A, non-B hepatitis: a clinical epidemiological and histological investigations. Scand J Gastroenterol 1983;18:519-27.
3. Sheen IS, Liaw YF, Lin DY, Chu CM. Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. J Hepatol 1996;24:525-31.
4. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998;840:45-50.
5. Tagawa H, Suzuki K, Oh S, Kawano M, Fujita A, Yasuhi Y. Influence of pregnancy on HB virus carriers (in Japanese). Nippon Sanka Fujinka Gakkai Zasshi (Acta Obstetrica Et Gynaccologica Japonica) 1987;39:24-30.
6. Romero-Gomez M, Suarez-Garcia E, Casanovas J, Nogales MC, Vargas J, Otero MA, et al. Influence of pregnancy in chronic hepatitis C virus infection (in Spanish). Med Clin (Barc) 1998; 111:641-4.
7. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R. Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 198;1:431-5.
8. Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984: 86:230-5.
9. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981;81:987-91.
10. Lok AS, Liang RH, Chju EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-8.
11. Grange JD, Abergel A, Amiot X, Chaslin-Ferbus D, Aygalenq P. Fouqueray B, et al. Interactions between chronic viral hepatitis C and pregnancy. Gastroenterol Clin Biol 1995;19:520-4.
12. Wejstal R, Widell A, Norkrans G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 1998;30:111-3.
13. Burns DN, Nourjah P, Wright DJ, Minkoff H, Landesman S, Rubinstein A, et al. Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol 1999;42:147-65.
14. Kishihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kashiwagi S. IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 1996;41:315-21.
15. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-7.
16. Löhr HF, Schmitz D, Arenz M, Weyer S, Gerken G, Meyer zum Büschenfelde KH. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies. J Hepatol 1999;31:407-15.
17. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th 1-associated cytokines. Hepatology 1996;24:759-65.
18. Matsumoto T, Ohkubo K, Yamamoto K, Ninoyama T, Abe M, Akbar SM, et al. Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. Hepatogastroenterology 1998;45:1630-4.
19. Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol 1996;24:377-84.
20. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L. et al. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C (HCV) infection. Clin Exp Immunol 1998;111:269-77.
21. Zylberberg H, Rimaniol AC, Pol S, Masson A, De-Groote D, Berthelot P, et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 1999;30:185-91.
22. Itoh Y, Okanoue T, Ohnishi N, Sakamoto M, Nishioji K, Nakagawa Y, et al. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1999;94: 1332-40.
23. Iio S, Hayashi N, Mita E, Ueda K, Mochizuki K, Hiramatsu N, et al. Serum levels of soluble Fas antigen in chronic hepatitis C patients. J Hepatol 1998;29:517-23.
24. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Imuunol 1997:158:5283-91.
25. Shimaoka Y, Hidaka Y, Tada H, Nakamura T, Mitsuda N, Morimoto Y, et al. Changes in cytokine production during and after normal pregnancy. Am J Reprod Immunol 2000;44:143-7.
26. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997;25:449-58.
27. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alpha. Hepatology 1996;24:6-9.
28. Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, et al. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 1997;109:458-63.
29. Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER. Interferon-induced chronic active hepatitis? Gastroenterology 1991;101:840-2.
30. Cervoni JP, Degos F, Marcellin P, Erlinger S. Acute hepatitis induced by alpha-interferon, associated with viral clearance, in chronic hepatitis C. J Hepatol 1997:27:1113-6.
31. Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, et al. Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course. J Gastroenterol 2000;35:607-12.
32. Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera JC, et al. Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992; 15:767-9.
33. Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassoni D, et al. A multicenter randomized controlled trial of recombinant interferon-alpha-2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.
34. Lok AS, Ghany MG, Watson G, Ayola B. Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B. J Viral Hepatol 1998; 5:171-8.